Evaluation of the Effects of Nicardipine on Entrectinib Metabolism in vitro and in Rats
{{output}}
Background: Entrectinib, a multi-target tyrosine kinase inhibitor (TKI) against TRK, ROS1, and ALK, is clinically approved for genetically-defined solid tumors. The prevalence of drug-drug interactions (DDIs) with increased use i... ...
